Dr. Anna Khimchenko is an experienced diagnostic imaging scientist and science communicator with a strong background in the medical device industry. With over 10 years of international experience in commercial development, market access, and med-tech R&D, she is well-versed in driving innovation in healthcare.
Anna earned her Ph.D. in Medical Science from the University of Basel, Switzerland, focusing on tomographic imaging and brain neurodegeneration. She furthered her expertise through postdoctoral training in Dermatology at Harvard Medical School and Massachusetts General Hospital, specializing in optical coherence tomography and cystic fibrosis.
Drawing on her extensive experience in translational research and healthcare innovation, Anna has made significant contributions to fields including wounds, sepsis, antimicrobial resistance, oncology, and neurology/neurodegeneration. Her expertise and dedication make her a valuable asset in advancing medical science and improving patient care.
As a Medical Science Liaison at Mimosa Diagnostics in Toronto, Anna serves as a pivotal conduit between cutting-edge medical technology and the healthcare sector, effectively connecting innovative solutions with key stakeholders.
Anna earned her Ph.D. in Medical Science from the University of Basel, Switzerland, focusing on tomographic imaging and brain neurodegeneration. She furthered her expertise through postdoctoral training in Dermatology at Harvard Medical School and Massachusetts General Hospital, specializing in optical coherence tomography and cystic fibrosis.
Drawing on her extensive experience in translational research and healthcare innovation, Anna has made significant contributions to fields including wounds, sepsis, antimicrobial resistance, oncology, and neurology/neurodegeneration. Her expertise and dedication make her a valuable asset in advancing medical science and improving patient care.
As a Medical Science Liaison at Mimosa Diagnostics in Toronto, Anna serves as a pivotal conduit between cutting-edge medical technology and the healthcare sector, effectively connecting innovative solutions with key stakeholders.
View contact details